• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G filed

    2/9/21 8:45:22 AM ET
    $IPOC
    Business Services
    Finance
    Get the next $IPOC alert in real time by email
    SC 13G 1 p21-0536sc13g.htm CLOVER HEALTH INVESTMENTS, CORP.

     

    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     
     
    SCHEDULE 13G
     
     
    Under the Securities Exchange Act of 1934
     
    (Amendment No.  )*
     

    Clover Health Investments, Corp.

    (Name of Issuer)
     

    Class A Common Stock, par value $0.0001 per share

    (Title of Class of Securities)
     

    18914F103

    (CUSIP Number)
     

    January 31, 2021

    (Date of event which requires filing of this statement)
     
     
    Check the appropriate box to designate the rule pursuant to which this Schedule 13G is filed:
     
    x Rule 13d-1(b)
    ¨ Rule 13d-1(c)
    ¨ Rule 13d-1(d)
     
    (Page 1 of 9 Pages)

     

    ______________________________

    * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 (the "Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

    CUSIP No. 18914F10313GPage 2 of 9 Pages

     

    1

    NAMES OF REPORTING PERSONS

    Greenoaks Capital Partners LLC

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) ¨

    3 SEC USE ONLY
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

    Delaware

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5

    SOLE VOTING POWER

    - 0 -

    6

    SHARED VOTING POWER

    96,331,338 shares of Class A Common Stock issuable upon conversion of 96,331,338 shares of Class B Common Stock

    7

    SOLE DISPOSITIVE POWER

    - 0 -

    8

    SHARED DISPOSITIVE POWER

    96,331,338 shares of Class A Common Stock issuable upon conversion of 96,331,338 shares of Class B Common Stock

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    96,331,338 shares of Class A Common Stock issuable upon conversion of 96,331,338 shares of Class B Common Stock

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    40.2%

    12

    TYPE OF REPORTING PERSON

    IA, OO

             

     

    CUSIP No. 18914F10313GPage 3 of 9 Pages

     

    1

    NAMES OF REPORTING PERSONS

    Neil Mehta

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) ¨

    3 SEC USE ONLY
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

    United States

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5

    SOLE VOTING POWER

    - 0 -

    6

    SHARED VOTING POWER

    96,331,338 shares of Class A Common Stock issuable upon conversion of 96,331,338 shares of Class B Common Stock

    7

    SOLE DISPOSITIVE POWER

    - 0 -

    8

    SHARED DISPOSITIVE POWER

    96,331,338 shares of Class A Common Stock issuable upon conversion of 96,331,338 shares of Class B Common Stock

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    96,331,338 shares of Class A Common Stock issuable upon conversion of 96,331,338 shares of Class B Common Stock

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    40.2%

    12

    TYPE OF REPORTING PERSON

    IN

             

     

     

    CUSIP No. 18914F10313GPage 4 of 9 Pages

     

    1

    NAMES OF REPORTING PERSONS

    Benjamin Peretz

    2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

    (a) ¨

    (b) ¨

    3 SEC USE ONLY
    4

    CITIZENSHIP OR PLACE OF ORGANIZATION

    United States

    NUMBER OF
    SHARES
    BENEFICIALLY
    OWNED BY
    EACH
    REPORTING
    PERSON WITH
    5

    SOLE VOTING POWER

    - 0 -

    6

    SHARED VOTING POWER

    96,331,338 shares of Class A Common Stock issuable upon conversion of 96,331,338 shares of Class B Common Stock

    7

    SOLE DISPOSITIVE POWER

    - 0 -

    8

    SHARED DISPOSITIVE POWER

    96,331,338 shares of Class A Common Stock issuable upon conversion of 96,331,338 shares of Class B Common Stock

    9

    AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

    96,331,338 shares of Class A Common Stock issuable upon conversion of 96,331,338 shares of Class B Common Stock

    10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES ¨
    11

    PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

    40.2%

    12

    TYPE OF REPORTING PERSON

    IN

             

     

    CUSIP No. 18914F10313GPage 5 of 9 Pages

     

     

    Item 1(a). NAME OF ISSUER.
       
      The name of the issuer is Clover Health Investments, Corp. (the "Company").

     

    Item 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
       
      The Company's principal executive offices are located at 725 Cool Springs Boulevard, Suite 320, Franklin, Tennessee, 37067.

     

    Item 2(a). NAME OF PERSON FILING:
       
      This statement is filed by:

     

      (i)

    Greenoaks Capital Partners LLC (the "Investment Manager"), a Delaware limited liability corporation and the investment adviser to certain funds and accounts (the "Greenoaks Funds"), with respect to the shares of Class A Common Stock (as defined in Item 2(d) below) issuable upon conversion of the Class B Common Stock of the Company (the "Class B Common Stock") directly held by the Greenoaks Funds; and

     

      (ii)

    Mr. Neil Mehta ("Mr. Mehta"), a managing member of the Investment Manager, with respect to the shares of Class A Common Stock issuable upon conversion of the shares of Class B Common Stock directly held by the Greenoaks Funds; and

     

      (iii) Mr. Benjamin Peretz ("Mr. Peretz"), a managing member of the Investment Manager, with respect to the shares of Class A Common Stock issuable upon conversion of the shares of Class B Common Stock directly held by the Greenoaks Funds.

     

      The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons."
       
      The filing of this statement should not be construed as an admission that any of the forgoing persons or any Reporting Person is, for the purposes of Section 13 of the Act, the beneficial owner of the shares of Class A Common Stock reported herein.  

     

    Item 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE:
       
      The address of the business office of each of the Reporting Persons is 535 Pacific Ave, 4th Floor, San Francisco, CA 94133.

     

    Item 2(c). CITIZENSHIP:
       
      The Investment Manager is a Delaware limited liability company.  Mr. Mehta and Mr. Peretz are each citizens of the United States.

     

    Item 2(d). TITLE OF CLASS OF SECURITIES:
       
      Class A Common Stock, par value $0.0001 per share (the "Class A Common Stock").

     

    CUSIP No. 18914F10313GPage 6 of 9 Pages

     

    Item 2(e). CUSIP NUMBER:
       
      18914F103

     

    Item 3. IF THIS STATEMENT IS FILED PURSUANT TO §§ 240.13d-1(b) OR 240.13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A:

     

      (a) ¨ Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o);
      (b) ¨ Bank as defined in Section 3(a)(6) of the Act (15 U.S.C. 78c);
      (c) ¨ Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c);
      (d) ¨ Investment company registered under Section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
      (e) x Investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E);
      (f) ¨

    Employee benefit plan or endowment fund in accordance with

    Rule 13d-1(b)(1)(ii)(F);

     

      (g) x

    Parent holding company or control person in accordance with

    Rule 13d-1(b)(1)(ii)(G);

      (h) ¨

    Savings association as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);

     

      (i) ¨

    Church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act (15 U.S.C. 80a-3);

     

      (j) ¨ Non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J);
      (k) ¨ Group, in accordance with Rule 13d-1(b)(1)(ii)(K).

     

      If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please
      specify the type of institution:  

     

    Item 4. OWNERSHIP.
       
      The information required by Items 4(a) - (c) is set forth in Rows 5 - 11 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
       
      The percentages set forth herein are calculated based upon 143,475,108 shares of Class A Common Stock, reported to be outstanding in the Company's Prospectus filed pursuant to Rule 424(b)(3) with the Securities and Exchange Commission on January 13, 2021.

     

     

    CUSIP No. 18914F10313GPage 7 of 9 Pages

     

    Item 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.
       
      Not applicable.

     

    Item 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON.
       
      See Item 2.  The Greenoaks Funds have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the shares of Class A Common Stock reported herein.  Greenoaks Capital Opportunities Fund, L.P., Greenoaks Magnolia Fund LP, Greenoaks Magnolia MS Fund LP - Pasteur Series, Greenoaks Capital MS LP - Lister Series and Greenoaks Capital MS LP - Joslin Series, certain Greenoaks Funds, have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, more than 5% of the Class A Common Stock.  

     

    Item 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY.
       
      Not applicable.

     

    Item 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP.
       
      Not applicable.

     

    Item 9. NOTICE OF DISSOLUTION OF GROUP.
       
      Not applicable.

     

    Item 10. CERTIFICATION.

     

      Each of the Reporting Persons hereby makes the following certification:
       
      By signing below each Reporting Person certifies that, to the best of his or its knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.

     

     

    CUSIP No. 18914F10313GPage 8 of 9 Pages

     

    SIGNATURES

    After reasonable inquiry and to the best of his or its knowledge and belief, each of the undersigned certify that the information set forth in this statement is true, complete and correct.

    DATED: February 9, 2021

     

    GREENOAKS CAPITAL PARTNERS LLC  
       
       
    By: /s/ Neil Mehta  
    Name:  Neil Mehta  
    Title:    Managing Member  
       
       
    /s/ Neil Mehta  
    Neil Mehta  
       
    /s/Benjamin Peretz  
    Benjamin Peretz  

     

     

     

    CUSIP No. 18914F10313GPage 9 of 9 Pages

     

    EXHIBIT 1

    JOINT ACQUISITION STATEMENT
    PURSUANT TO RULE 13d-1(k)

    The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint acquisition statements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate.

    DATED: February 9, 2021

     

     

    GREENOAKS CAPITAL PARTNERS LLC  
       
       
    By: /s/ Neil Mehta  
    Name:  Neil Mehta  
    Title:    Managing Member  
       
       
    /s/ Neil Mehta  
    Neil Mehta  
       
    /s/Benjamin Peretz  
    Benjamin Peretz  

     

     

    Get the next $IPOC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $IPOC

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $IPOC
    SEC Filings

    View All

    SEC Form 424B3 filed

    424B3 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Filer)

    3/1/21 4:52:21 PM ET
    $IPOC
    Business Services
    Finance

    SEC Form 424B3 filed

    424B3 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Filer)

    3/1/21 4:53:29 PM ET
    $IPOC
    Business Services
    Finance

    SEC Form 8-K filed

    8-K - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Filer)

    3/1/21 4:47:30 PM ET
    $IPOC
    Business Services
    Finance

    $IPOC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by Llc Partners Capital Greenoaks

    3 - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Issuer)

    1/19/21 4:15:22 PM ET
    $IPOC
    Business Services
    Finance

    $IPOC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Clover Health and Social Capital Hedosophia Holdings Corp. III Announce Closing of Business Combination

    NASHVILLE, Tenn. & PALO ALTO, Calif.--(BUSINESS WIRE)--Clover Health Investments, Corp. (“Clover”), an innovative technology company improving health outcomes for America's seniors, and Social Capital Hedosophia Holdings Corp. III (NYSE: IPOC) ("SCH"), a publicly traded special purpose acquisition company, today completed their previously announced business combination to form one of the nation’s fastest growing publicly-traded Medicare Advantage insurers. The newly formed company is named Clover Health Investments, Corp. (“Clover Health” or the “Company”) and its shares of Class A common stock and warrants will start trading on The Nasdaq Global Select Market (“Nasdaq”) under the n

    1/7/21 12:21:00 PM ET
    $IPOC
    Business Services
    Finance

    Social Capital Hedosophia III Shareholders Approve Business Combination with Clover Health

    PALO ALTO, Calif.--(BUSINESS WIRE)--Social Capital Hedosophia Holdings Corp. III (NYSE: IPOC) (“SCH” and, after the Domestication and business combination as described below, “Clover Health”), a publicly traded special purpose acquisition company, announced today that in an extraordinary general meeting on January 6, 2021, its shareholders voted to approve its proposed business combination (the “business combination”) with Clover Health Investments, Corp. (“Clover”). Approximately 99.5% of the votes cast at the meeting, representing approximately 65.0% of SCH’s outstanding shares, voted to approve the business combination. The business combination is expected to close on January 7,

    1/6/21 2:00:00 PM ET
    $IPOC
    Business Services
    Finance

    $IPOC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed

    SC 13G/A - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Subject)

    2/12/21 4:27:49 PM ET
    $IPOC
    Business Services
    Finance

    SEC Form SC 13G filed

    SC 13G - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Subject)

    2/9/21 8:45:22 AM ET
    $IPOC
    Business Services
    Finance

    SEC Form SC 13G/A filed

    SC 13G/A - CLOVER HEALTH INVESTMENTS, CORP. /DE (0001801170) (Subject)

    2/4/21 11:25:59 AM ET
    $IPOC
    Business Services
    Finance